ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Trifluoroacetic acid → 2-[7,8-Difluoro-3-(1H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide

HRID 343232
ノート
印刷プレビュー

反応式

HRID 343232 の反応式
FC(F)(F)C(O)=O.[F:8][C:9]1[C:59]([F:60])=[CH:58][C:12]2[N:13]([CH2:43][C:44]([N:46]([CH:55]([CH3:57])[CH3:56])[C:47]3[CH:52]=[CH:51][C:50]([O:53][CH3:54])=[CH:49][CH:48]=3)=[O:45])[C:14](=[O:42])[CH:15]([CH2:25][C:26]3[C:34]4[C:29](=[CH:30][CH:31]=[CH:32][CH:33]=4)[N:28](C(OC(C)(C)C)=O)[N:27]=3)[C:16](=[O:24])[N:17]([C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)[C:11]=2[CH:10]=1>>[F:8][C:9]1[C:59]([F:60])=[CH:58][C:12]2[N:13]([CH2:43][C:44]([N:46]([CH:55]([CH3:57])[CH3:56])[C:47]3[CH:48]=[CH:49][C:50]([O:53][CH3:54])=[CH:51][CH:52]=3)=[O:45])[C:14](=[O:42])[CH:15]([CH2:25][C:26]3[C:34]4[C:29](=[CH:30][CH:31]=[CH:32][CH:33]=4)[NH:28][N:27]=3)[C:16](=[O:24])[N:17]([C:18]3[CH:19]=[CH:20][CH:21]=[CH:22][CH:23]=3)[C:11]=2[CH:10]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

3

反応物 2

HCID 6422Trifluoroacetic acidHCID 867535922-[7,8-difluoro-3-(1-tertbutoxycarbonyl-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide

生成物 1

HCID 1784923812-[7,8-Difluoro-3-(1H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide収率 99.8%

実験手順

To a solution of 5.0 mL trifluoroacetic acid under nitrogen is added 0.500 g of 2-[7,8-difluoro-3-(1-tertbutoxycarbonyl-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide, prepared as in Intermediate 67, (0.697 mmol). After stirring for 1.5 hrs., the trifluoroacetic acid is removed in vacuo and the residue is partitioned between methylene chloride and aqueous sodium hydroxide (1N) and transferred to a separatory funnel. The layers were separated and the organic layer is back-extracted with methylene chloride. The organic layers were combined, dried over anhydrous sodium sulfate, filtered, evaporated in vacuo to a residue and then triturated with hexane. Hexane is removed in vacuo and the remaining solid is dried under high vacuum to provide 430 mg of the title compound as an off-white solid: 1H NMR (300 MHz, CDCl3) δ7.93 (d, 1H, J=8.2), 7.51 (m, 2H), 7.41 (m, 2H), 7.29 (m, 7H), 7.15 (m, 1H), 7.00 (m, 2H), 6.82 (m, 1H), 5.01 (m, 1H), 4.36 (m, 1H), 4.32 (d, 1H, J=17.1), 4.19 (d, 1H, J=16.7), 3.88 (s, 3H), 3.87 (m, 1H), 3.74 (dd, 1H, J=6.0, 16.1), 1.10 (d, 6H, J=6.8); low resolution MS (FAB)m/e 624 (MH+).

後処理

  1. custom, the trifluoroacetic acid is removed in vacuo
  2. customthe residue is partitioned between methylene chloride and aqueous sodium hydroxide (1N)
  3. customtransferred to a separatory funnel
  4. customThe layers were separated
  5. extractionthe organic layer is back-extracted with methylene chloride
  6. dry with materialdried over anhydrous sodium sulfate
  7. filtrationfiltered
  8. customevaporated in vacuo to a residue
  9. customtriturated with hexane
  10. customHexane is removed in vacuo
  11. customthe remaining solid is dried under high vacuum

出典と根拠

ORDレコード
ord-2a9457f03eb24db88ba0253495a6d8c6
出典データセット
uspto-grants-1999_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05859007

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート